Comment on Rosenstock and Ferrannini. Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors. Diabetes Care 2015;38:1638-1642
1 Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of California, Davis, Sacramento, CA wgcushard@ucdavis.edu wcushardmd@gmail.com.